↓ Skip to main content

Dove Medical Press

GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2023
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
32 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
27 Mendeley
Title
GLP-1RA Liraglutide and Semaglutide Improves Obesity-Induced Muscle Atrophy via SIRT1 Pathway.
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, August 2023
DOI 10.2147/dmso.s425642
Pubmed ID
Authors

Jie Xiang, Liyan Qin, Jinling Zhong, Ning Xia, Yuzhen Liang

X Demographics

X Demographics

The data shown below were collected from the profiles of 32 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 19%
Student > Doctoral Student 2 7%
Student > Ph. D. Student 2 7%
Professor 1 4%
Lecturer > Senior Lecturer 1 4%
Other 2 7%
Unknown 14 52%
Readers by discipline Count As %
Medicine and Dentistry 5 19%
Biochemistry, Genetics and Molecular Biology 2 7%
Linguistics 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Agricultural and Biological Sciences 1 4%
Other 1 4%
Unknown 16 59%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2024.
All research outputs
#2,477,769
of 26,180,352 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#119
of 1,207 outputs
Outputs of similar age
#42,386
of 366,355 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 27 outputs
Altmetric has tracked 26,180,352 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,207 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 366,355 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.